Skip to content
Screener

aTyr Pharma ATYR Q2 2025 earnings

Reported August 7, 2025 · Before market open

Revenue-
EPS-$0.22Miss by $0.04
EPS estimate-$0.18

Next report

Nov 5, 2026 (in 3 months)
Revenue estimate$2.5M
EPS estimate-$0.17

Financials

Q2 2025

Income statement

See full
Revenue-—
Operating income-$20.3M-17.3%
Net income-$19.5M-19.8%
EPS (diluted)-$0.22+4.3%

Balance sheet

See full
Cash & equivalents$17.2M+153%
Total debt$13.2M-7.9%
Total equity$74.8M-8.3%
Total assets$101.5M-4.2%

Cash flow

See full
Operating cash flow-$13.9M+32.1%
CapEx$9.0K+12.5%
Free cash flow-$13.9M+32.0%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$472.61M+339%
Enterprise value$468.63M+307%

Returns & leverage

See full
Return on equity-85.2%+52.6pp
Debt / equity0.2×0.0×
Current ratio5.6×-2.0×

FAQ

When did aTyr Pharma report Q2 2025 earnings?
aTyr Pharma (ATYR) reported Q2 2025 earnings on August 7, 2025 before market open.
What were aTyr Pharma's Q2 2025 revenue and EPS?
aTyr Pharma reported revenue of - and eps of $-0.22 for Q2 2025.
Did aTyr Pharma beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.18 by $0.04.
How did aTyr Pharma's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 4.3% from $-0.23.
Where can I find aTyr Pharma's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001339970-25-000007) and the 10-Q periodic report (0001339970-25-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.